DrugPatentWatch Database Preview
Details for Patent: 9,586,010
» See Plans and Pricing
Which drugs does patent 9,586,010 protect, and when does it expire?
Patent 9,586,010 protects EPIPEN and EPIPEN JR. and is included in one NDA.
This patent has forty-five patent family members in eighteen countries.
Summary for Patent: 9,586,010
| Title: | Automatic injector with needle cover |
| Abstract: | An auto-injector automatically dispenses a predetermined dose of medicament upon activation. The auto-injector includes a needle cover operative to engage an injection site and activate the injector. The needle cover is configured to move from a locked retracted position prior to a medicament dispensing operation to a locked extended position after the medicament dispensing operation. The non-removable needle cover prevents contact with the needle both before and after the medicament dispensing operation. |
| Inventor(s): | Mesa; C. Michael (Boyds, MD), Tomellini; Dalita Rosemarie (Rehoboth, MA), Bremley; Mark Bumb (Edwardsville, IL), Raven; Sophie Rebecca (Swavesey, GB), Murphy; Martin Joseph (Letchworth Garden City, IE), Rochford; Craig Malcolm (Andover, GB), Kirkwood; Stephen Philip (Haynes, GB) |
| Assignee: | Meridian Medical Technologies, Inc. (Columbia, MD) |
| Application Number: | 13/788,509 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,586,010 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 9,586,010
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Speciality Lp | EPIPEN | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 019430-001 | Dec 22, 1987 | AB | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Mylan Speciality Lp | EPIPEN JR. | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 019430-002 | Dec 22, 1987 | AB | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,586,010
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2005271355 | Start Trial | |||
| Australia | 2010201665 | Start Trial | |||
| Australia | 2013222015 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
